Celon Pharma S.A.

WSE:CLN.WA

15.96 (PLN) • At close December 14, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) PLN.

202320222021202020192018201720162015201420132012
Revenue 213.921161.915169.559139.27102.247125.245107.12128.778107.5498.09971.6440.109
Cost of Revenue 66.81966.46261.71532.01123.35528.17624.46628.49130.02420.26514.7697.923
Gross Profit 147.10295.453107.844107.25978.89297.06882.654100.28777.51677.83456.87232.186
Gross Profit Ratio 0.6880.590.6360.770.7720.7750.7720.7790.7210.7930.7940.802
Reseach & Development Expenses 0.6862.99949.05442.254000008.8564.4090.97
General & Administrative Expenses 0037.38410.94815.87818.33618.68519.17516.44551.43139.06631.601
Selling & Marketing Expenses 000019.5330000000
SG&A 111.1213.10337.38410.94815.87818.33618.68519.17516.44551.43139.06631.601
Other Expenses 62.544132.74981.04558.99856.79443.39837.94534.22114.987000
Operating Expenses 174.344132.749118.42969.94672.67361.73456.6353.39631.43119.48834.8229.58
Operating Income -27.242-34.735-13.66636.8186.89835.61125.99147.05747.229.21221.9672.315
Operating Income Ratio -0.127-0.215-0.0810.2640.0670.2840.2430.3650.4390.2980.3070.058
Total Other Income Expenses Net 7.2740.89-4.634-1.9150.9111.8824.922-0.27-0.69728.9440.0230.03
Income Before Tax -19.968-36.446-15.08722.0697.80937.49430.91346.78746.50358.15621.992.345
Income Before Tax Ratio -0.093-0.225-0.0890.1580.0760.2990.2890.3630.4320.5930.3070.058
Income Tax Expense 8.1562.831-3.480.574-4.1267.7975.2988.989.3235.9494.0321.012
Net Income -28.124-39.277-11.60721.49511.93529.69725.61537.80737.1852.20717.9581.334
Net Income Ratio -0.131-0.243-0.0680.1540.1170.2370.2390.2940.3460.5320.2510.033
EPS -0.55-0.77-0.250.480.270.660.570.840.831.740.60.04
EPS Diluted -0.55-0.77-0.250.480.270.660.570.840.831.740.60.045
EBITDA 32.7149.3227.80830.3726.83955.85348.53860.82455.05534.36226.2866.654
EBITDA Ratio 0.1530.0580.1640.2180.2620.4460.4530.4720.5120.350.3670.166